Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment.
作者信息
Stahl Andreas, Nakanishi Hidehiko, Lepore Domenico, Wu Wei-Chi, Azuma Noriyuki, Jacas Carlos, Athanikar Aditya, Vitti Robert, Chu Karen, Iveli Pablo, Zhao Fei, Schlief Sarah, Leal Sergio, Schmelter Thomas, Miller Thomas, Köfüncü Evra, Fielder Alistair
机构信息
Department of Ophthalmology, University Medicine Greifswald, Ferdinand Sauerbruch Straße, Greifswald 17475, Germany.
Division of Neonatal Intensive Care Medicine, Department of Advanced Medicine, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Japan.
出版信息
Ther Adv Ophthalmol. 2025 May 7;17:25158414251321730. doi: 10.1177/25158414251321730. eCollection 2025 Jan-Dec.
Abstract
摘要
相似文献
1
Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment.
Ther Adv Ophthalmol. 2025 May 7;17:25158414251321730. doi: 10.1177/25158414251321730. eCollection 2025 Jan-Dec.
2
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
JAMA Netw Open. 2024 Apr 1;7(4):e248383. doi: 10.1001/jamanetworkopen.2024.8383.
3
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
JAMA. 2022 Jul 26;328(4):348-359. doi: 10.1001/jama.2022.10564.
4
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Eye (Lond). 2024 Jun;38(8):1444-1453. doi: 10.1038/s41433-023-02919-9. Epub 2024 Jan 10.
5
Comparison of the Efficacy Between Intravitreal Aflibercept and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity.
J Pediatr Ophthalmol Strabismus. 2020 Jan 1;57(1):54-60. doi: 10.3928/01913913-20191104-01.
6
Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity.
Int J Retina Vitreous. 2021 Oct 13;7(1):60. doi: 10.1186/s40942-021-00334-4.
7
Intravitreal aflibercept injection in Indian eyes with retinopathy of prematurity.
Indian J Ophthalmol. 2019 Jun;67(6):884-888. doi: 10.4103/ijo.IJO_708_18.
8
Correction: Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study.
Eye (Lond). 2024 Jun;38(8):1599-1600. doi: 10.1038/s41433-024-02948-y.
9
Efficacy of Aflibercept Treatment and Its Effect on the Retinal Perfusion in the Oxygen-Induced Retinopathy Mouse Model of Retinopathy of Prematurity.
Ophthalmic Res. 2021;64(1):91-98. doi: 10.1159/000509380. Epub 2020 Jun 12.
10
Efficacy of intravitreal aflibercept monotherapy in retinopathy of prematurity evaluated by periodic fluorescence angiography and optical coherence tomography.
Int Ophthalmol. 2019 Oct;39(10):2161-2169. doi: 10.1007/s10792-018-1040-x. Epub 2018 Nov 26.
本文引用的文献
1
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
JAMA Netw Open. 2024 Apr 1;7(4):e248383. doi: 10.1001/jamanetworkopen.2024.8383.
2
Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries.
Pediatric Health Med Ther. 2023 Feb 15;14:59-69. doi: 10.2147/PHMT.S391591. eCollection 2023.
3
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
JAMA. 2022 Jul 26;328(4):348-359. doi: 10.1001/jama.2022.10564.
4
Complications of retinopathy of prematurity treatment.
Curr Opin Ophthalmol. 2021 Sep 1;32(5):475-481. doi: 10.1097/ICU.0000000000000783.
5
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial.
Lancet. 2019 Oct 26;394(10208):1551-1559. doi: 10.1016/S0140-6736(19)31344-3. Epub 2019 Sep 12.
6
Screening Examination of Premature Infants for Retinopathy of Prematurity.
Pediatrics. 2018 Dec;142(6). doi: 10.1542/peds.2018-3061.
7
Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity.
Oman J Ophthalmol. 2014 Sep;7(3):116-9. doi: 10.4103/0974-620X.142592.
8
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.
N Engl J Med. 2011 Feb 17;364(7):603-15. doi: 10.1056/NEJMoa1007374.
9
Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.
Trans Am Ophthalmol Soc. 2004;102:233-48; discussion 248-50.
10
Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.
Arch Ophthalmol. 2003 Dec;121(12):1684-94. doi: 10.1001/archopht.121.12.1684.
Zotero 插件